SciSparc 
Welcome,         Profile    Billing    Logout  
 3 Products   0 Diseases  3 Products   3 Trials   34 News 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dronabinol/palmitoylethanolamide (SCI-110) / SciSparc
NAVE-Sci-001, NCT05239390: SCI-110 for Alzheimer Disease and Agitation

Recruiting
2a
20
RoW
SCI -110, Dronabinol and PEA
The Israeli Medical Center for Alzheimer's
Alzheimer Disease
06/23
06/23
2018-000014-38: A Phase IIa Study to Determine the Safety, Tolerability and Efficacy of a daily oral dose of THX-110 in Adult Patients with Tourette Syndrome (TS)

Not yet recruiting
2
60
Europe
THX-110 [Dronabinol], THX-110 [PEA (Palmitoylethanolamide)], Capsule, soft, Tablet, Dronabinol Capsules, USP
Therapix Biosciences Ltd., Therapix Biosciences Ltd.
Tourette Syndrome, Neuropsychiatric disorder characterized by multiple motor or vocal tics., Diseases [C] - Nervous System Diseases [C10]
 
 
NCT05126888: SCI-110 in the Treatment of Tourette Syndrome

Not yet recruiting
2
164
Europe, US, RoW
SCI-110, Placebo
SciSparc
Tourette Syndrome
10/25
02/26
Respectrum (cannabidiol/palmitoylethanolamide) / SciSparc
NCT05182697: SCI-210 in the Treatment of Children and Young Adults With AutismEvaluate the Safety, Tolerability and Efficacy of SCI-210 in Children With Autism Spectrum Disorder (ASD)

Recruiting
N/A
60
RoW
SCI-210, Oral CBD oil
SciSparc, Negev Autism Center Soroka University Medical Center
Autism Spectrum Disorder (ASD)
05/26
06/26
SCI-160 / SciSparc
No trials found
THX-150 / SciSparc
No trials found
low dose dronabinol (THX-130) / SciSparc
No trials found
CannAmide (palmitoylethanolamide) / SciSparc
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dronabinol/palmitoylethanolamide (SCI-110) / SciSparc
NAVE-Sci-001, NCT05239390: SCI-110 for Alzheimer Disease and Agitation

Recruiting
2a
20
RoW
SCI -110, Dronabinol and PEA
The Israeli Medical Center for Alzheimer's
Alzheimer Disease
06/23
06/23
2018-000014-38: A Phase IIa Study to Determine the Safety, Tolerability and Efficacy of a daily oral dose of THX-110 in Adult Patients with Tourette Syndrome (TS)

Not yet recruiting
2
60
Europe
THX-110 [Dronabinol], THX-110 [PEA (Palmitoylethanolamide)], Capsule, soft, Tablet, Dronabinol Capsules, USP
Therapix Biosciences Ltd., Therapix Biosciences Ltd.
Tourette Syndrome, Neuropsychiatric disorder characterized by multiple motor or vocal tics., Diseases [C] - Nervous System Diseases [C10]
 
 
NCT05126888: SCI-110 in the Treatment of Tourette Syndrome

Not yet recruiting
2
164
Europe, US, RoW
SCI-110, Placebo
SciSparc
Tourette Syndrome
10/25
02/26
Respectrum (cannabidiol/palmitoylethanolamide) / SciSparc
NCT05182697: SCI-210 in the Treatment of Children and Young Adults With AutismEvaluate the Safety, Tolerability and Efficacy of SCI-210 in Children With Autism Spectrum Disorder (ASD)

Recruiting
N/A
60
RoW
SCI-210, Oral CBD oil
SciSparc, Negev Autism Center Soroka University Medical Center
Autism Spectrum Disorder (ASD)
05/26
06/26
SCI-160 / SciSparc
No trials found
THX-150 / SciSparc
No trials found
low dose dronabinol (THX-130) / SciSparc
No trials found
CannAmide (palmitoylethanolamide) / SciSparc
No trials found

Download Options